Udo Gaipl

No ORCID on file · 1 paper in corpus

2026

First-Line Immune Checkpoint Inhibitors Versus Chemotherapy in Delaying Quality of Life Deterioration in Advanced NSCLC: A Systematic Review and Meta- Analysis

·doi:10.21203/rs.3.rs-8886255/v1

Abstract Backgroud: Immune checkpoint inhibitors (ICIs) have transformed first-line treatment for advanced non–small-cell lung cancer (aNSCLC). While overall survival(OS) remains the primary endpoint, health-related quality of life (HRQ…